Silke Aigner

1.5k total citations
18 papers, 1.1k citations indexed

About

Silke Aigner is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Allergy and Immunology. According to data from OpenAlex, Silke Aigner has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Immunology and Allergy and 6 papers in Immunology. Recurrent topics in Silke Aigner's work include Cell Adhesion Molecules Research (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and T-cell and B-cell Immunology (4 papers). Silke Aigner is often cited by papers focused on Cell Adhesion Molecules Research (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and T-cell and B-cell Immunology (4 papers). Silke Aigner collaborates with scholars based in Germany, United States and Hungary. Silke Aigner's co-authors include Peter Altevogt, Marei Sammar, Marcus Hubbe, Dietmar Vestweber, Zev Sthoeger, Carroll L. Ramos, Ali Hafezi‐Moghadam, Michael B. Lawrence, Klaus Ley and Jan Friederichs and has published in prestigious journals such as The Journal of Cell Biology, Blood and The FASEB Journal.

In The Last Decade

Silke Aigner

17 papers receiving 1.0k citations

Peers

Countries citing papers authored by Silke Aigner

Since Specialization

Citations

This map shows the geographic impact of Silke Aigner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Aigner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Aigner more than expected).

Fields of papers citing papers by Silke Aigner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silke Aigner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Aigner. The network helps show where Silke Aigner may publish in the future.

Co-authorship network of co-authors of Silke Aigner

This figure shows the co-authorship network connecting the top 25 collaborators of Silke Aigner. A scholar is included among the top collaborators of Silke Aigner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silke Aigner. Silke Aigner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Efficacy and safety of human fibrinogen concentrate (BT524) in patients with major haemorrhage undergoing major orthopaedic or abdominal surgery (AdFIrst): a randomised, active-controlled, multicentre, partially blinded, phase 3 non-inferiority trial 2025 ·EClinicalMedicine ·Niels Rahe‐Meyer, Ashok Roy, Hans Trouillier, (unknown), (unknown), (unknown), (unknown), Ümniye Balaban, (unknown), Jörg Schüttrumpf, Silke Aigner, (unknown)	0
2	BT595, a 10% Human Normal Immunoglobulin, for Replacement Therapy of Primary Immunodeficiency Disease: Results of a Subcohort Analysis in Children 2022 ·Journal of Clinical Immunology ·Gergely Kriván, Michael Borte, Pere Soler‐Palacín, Joseph A. Church, (unknown), James B. Harris, Phil Lieberman, Isaac Melamed, James N. Moy, Réka Simon, Silke Aigner, (unknown), Christiane Staiger	2
3	Efficacy and safety of BT595 (10% human intravenous immunoglobulin) in adult patients with chronic immune thrombocytopenia 2022 ·Transfusion Medicine ·Judit Demeter, Aryan Hamed, (unknown), Nada Suvajdžić, Silke Aigner, (unknown), Christiane Staiger	4
4	Efficacy, safety and pharmacokinetics of a new 10% normal human immunoglobulin for intravenous infusion, BT595, in children and adults with primary immunodeficiency disease 2022 ·Vox Sanguinis ·Gergely Kriván, Michael Borte, James B. Harris, William R. Lumry, Silke Aigner, (unknown), Christiane Staiger	3
5	Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial 2018 ·Annals of the Rheumatic Diseases ·Ronald van Vollenhoven, Edward Keystone, Vibeke Strand, César Pacheco‐Tena, Jiří Vencovský, Frank Behrens, (unknown), (unknown), Faı̈za Rharbaoui, (unknown), (unknown), (unknown), Xuefei Zhou, Silke Aigner, Benjamin Dälken, Andrea Wartenberg‐Demand	9
6	Tregalizumab – A Monoclonal Antibody to Target Regulatory T Cells 2016 ·Frontiers in Immunology ·Martin König, Faı̈za Rharbaoui, Silke Aigner, Benjamin Dälken, Jörg Schüttrumpf	32
7	Radiation Exposure and Contrast Volume Differ between Transapical and Transfemoral Aortic Valve Implantation with the Edwards SAPIEN Aortic Valve 2015 ·The Thoracic and Cardiovascular Surgeon ·Michael A. Erb, (unknown), (unknown), Silke Aigner, Christian Butter, Johannes M. Albes, Martin Hartrumpf	3
8	BT062, a CD138-Specific Immunoconjugate, Demonstrates Superior In Vivo Anti-Myeloma Efficacy In Combination with Lenalidomide or Bortezomib 2010 ·Blood ·(unknown), (unknown), Silke Aigner, (unknown), Olga Ab, Kathleen R. Whiteman, Teru Hideshima, Robert J. Lutz, Frank Osterroth, Christoph Uherek	5
9	(1125) - Selective Activation of Naturally Occurring Regulatory T Cells (Tregs) by the Monoclonal Antibody (mAb) BT-061. Markers of Clinical Activity and Early Phase II Results in Patients with Rheumatoid Arthritis (RA) 2010 ·(unknown), (unknown), Christina Trollmo, (unknown), Christian Becker, Helmut Jonuleit, Vibeke Strand, Silke Aigner, Niklas Czeloth, (unknown), André Engling, (unknown), (unknown), Frank Osterroth, Christoph Uherek, Andrea Wartenberg‐Demand, Olga Ershova, Tatiana Sotnikova, (unknown)	4
10	226 High in vivo anti-tumor activity of the immunoconjugate BT-062 against CD138 positive solid tumors 2010 ·European Journal of Cancer Supplements ·Chantal Zuber, Benjamin Dälken, Silke Aigner, (unknown), (unknown), Christina N. Carrigan, Robert J. Lutz, G Payne, Frank Osterroth, Christoph Uherek	1
11	Peripheral T‐cell tolerance: the contribution of permissive T‐cell migration into parenchymal tissues of the neonate 1999 ·Immunological Reviews ·Judith Alferink, Silke Aigner, Roland Reibke, Günter J. Hämmerling, Bernd Arnold	24
12	CD24 mediates rolling of breast carcinoma cells on P‐selectin 1998 ·The FASEB Journal ·Silke Aigner, Carroll L. Ramos, Ali Hafezi‐Moghadam, Michael B. Lawrence, Jan Friederichs, Peter Altevogt, Klaus Ley	235
13	Heat-stable antigen (mouse CD24) in the brain: dual but distinct interaction with P-selectin and L1 1997 ·Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·Marei Sammar, Silke Aigner, Peter Altevogt	49
14	CD24, a Mucin-Type Glycoprotein, Is a Ligand for P-Selectin on Human Tumor Cells 1997 ·Blood ·Silke Aigner, Zev Sthoeger, Mina Fogel, Erich Weber, Jürg A. Zarn, (unknown), (unknown), Dietmar Vestweber, Rolf A. Stahel, Marei Sammar, Peter Altevogt	271
15	L1 adhesion molecule on human lymphocytes and monocytes: expression and involvement in binding to αvβ3 integrin 1996 ·European Journal of Immunology ·(unknown), (unknown), Silke Aigner, (unknown), (unknown), John T. Kemshead, Peter Mӧller, Reinhard Schwartz‐Albiez, Peter Altevogt	98
16	Heat stable antigen (mouse CD24) supports myeloid cell binding to endothelial and platelet P-selectin 1995 ·International Immunology ·Silke Aigner, (unknown), Marcus Hubbe, Marei Sammar, Zev Sthoeger, E C Butcher, Dietmar Vestweber, Peter Altevogt, Stefan H. E. Kaufmann	91
17	The L1 adhesion molecule is a cellular ligand for VLA-5. 1995 ·The Journal of Cell Biology ·(unknown), Silke Aigner, Marcus Hubbe, Hideo Yagita∥, Peter Altevogt	127
18	Heat-stable antigen (CD24) as ligand for mouse P-selectin 1994 ·International Immunology ·Marei Sammar, Silke Aigner, Marcus Hubbe, Volker Schirrmacher, Melitta Schachner, Dietmar Vestweber, Peter Altevogt	100

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact